Pro-Dex, Inc.
PDEX Healthcare Medical Instruments & Supplies
Pro-Dex, Inc.’s revenue for fiscal 2026 (year ended June 2026) was $77.5 million, up 16.5% from fiscal 2025. In the quarter to June 2026, revenue grew 16.7%, EPS grew 143.2%, free cash flow fell 79.0% and total debt rose 43.5%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.
Follow PDEX
Pro-Dex, Inc. (PDEX) P/E ratio
As of 16 October 2026, Pro-Dex, Inc. (PDEX) trades at a P/E ratio of 13.8×. Over the past ten years it has ranged from 0.0× (December 2015) to 62.7× (March 2016); the current reading is higher than 41% of that period. That is below the Medical Instruments & Supplies industry median of 33.8× and below the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2026 | 13.8× | (12.46%) |
| FY2025 | 15.8× | (45.71%) |
| FY2024 | 29.1× | 183.65% |
| FY2023 | 10.3× | (19.16%) |
| FY2022 | 12.7× | (36.26%) |
| FY2021 | 19.9× | 75.35% |
| FY2020 | 11.4× | (15.33%) |
| FY2019 | 13.4× | (22.71%) |
| FY2018 | 17.4× | 255.95% |
| FY2017 | 4.9× | (82.45%) |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 13.8× | 4.26% |
| Mar 2026 | 13.3× | 19.72% |
| Dec 2025 | 11.1× | 12.37% |
| Sep 2025 | 9.9× | (37.59%) |
| 42 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| SMTI Sanara MedTech Inc. compare | n/m |
| STXS Stereotaxis Inc. compare | n/m |
| KRMD KORU Medical Systems, Inc. compare | n/m |
| NYXH Nyxoah SA compare | n/m |
| OSUR OraSure Technologies, Inc. compare | n/m |
| EMBC Embecta Corp. compare | 4.2× |
| PDEX Pro-Dex, Inc. | 13.8× |
| UTMD Utah Medical Products, Inc. compare | 22.7× |
| ZJYL Jin Medical International Ltd. compare | — |
| Medical Instruments & Supplies industry median | 33.8× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)